Switzerland
Björn Böckenförde to leave Zurmont Madison
Böckenförde co-founded the company in 2001
Cequr raises $100m series-C
Insulin infusion device to go on sale next year
Waterland exits Seniocare to Swiss Prime Site
Seniocare acquired three additional homes during holding period
Lakestar closes second venture fund on €350m
Vehicle surpasses VC's €135m first fund
KKR acquires minority stake in Software One
Founding partners and management retain control of the business.
LifeCare Partners and LSP lead CHF 15m round for Kuros
Deal marks third investment in Swiss biotech sector this year
PAI sells Swissport International for CHF 2.7bn
Chinese trade buyer HNA Group picks up asset from PAI
Permira-backed Pantheon Healthcare bolts on IBSL
Deal marks fourth acquisition for diagnostic imaging group
Memo Therapeutics raises CHF 2.3m series-A
Zurich biotech attracts funding from Redalpine
Suikkonen joins Lyrique as partner
Kaarina Suikkonen joins Swiss fund-of-funds manager
Invision appoints new partner
Martin Spirig replaces Gerhard Weisschaedel
Investindustrial promotes four to senior principal
GP rewards quartet for a combined 45 years of service
VC-backed Biocartis lists with €450m market cap
Biocartis raises €100m in offering
Mountain Partners acquires Netstart Venture
Business angel Kollman sells venture capital company to Swiss VC
HBM Partners backs APR
Swiss firm holds 56% stake alongside Bright Technology Fund
Charles River Ventures backs ProtonMail
Email encryption service raises $2m from US-based VC
Sunstone leads €8.7m Prexton Therapeutics round
Ysios Capital and MS Ventures also take part in series-A
Redalpine backs CHF 4.5m easySYS round
Swiss VC firm invests alongside family office Armada
EQT in SEK 1.94bn final exit from Sanitec
GP sells 20% stake held since 2013 IPO
Swiss currency move: the potential impact on private equity
Cap removal does not lead to loss of interest
VC backers divest GlycoVaxyn to GSK
Deal values biopharmaceutical company at $212m
Bridgepoint sells Infront to Wanda for €1.05bn
Deal value understood to be 11.9x EBITDA, generating 37% IRR for Bridgepoint
Ambienta appoints Vorndran Mannheims' Helling as partner
GP also promotes two new principals
LGT’s Crown Co-investment Opportunities fund holds final close
Vehicle has already completed 11 co-investments